BIO-key Forecasts 50% H1 Revenue Surge, Projects Positive Net Income
BKYI sits 24% above its 52-week low of $0.49 on light trading volume (0.1× avg).
Summary
BIO-key International, a biometric authentication firm, has issued strong guidance, expecting its first-half 2026 revenue to increase by 50% year-over-year to approximately $5 million. Crucially, the company also projects positive net income for H1'26, a significant turnaround from a $1.9 million net loss in the prior year period. This positive outlook is driven by expanded software license renewals, including a $1.04 million contract with a foreign retail bank, and over $1 million in new hardware contracts. For a micro-cap company, this anticipated shift to profitability and substantial revenue growth is highly material and could significantly impact investor sentiment and the stock's valuation. Traders will be closely monitoring the actual H1 results to confirm this guidance and for further updates on larger contract opportunities expected in H2'26 and 2027.
At the time of this announcement, BKYI was trading at $0.61 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.6M. The 52-week trading range was $0.49 to $1.97. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.